Lobbying

Inperium's latest lobbying report covers Q2 2026, at $30K. The four quarters Q4 2025–Q3 2026 total $90K. Its first report covers Q3 2024; the issues it reports most are Health Issues.

Inperium

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$90K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q3 2024
The first quarter a report named it

Lobbying by quarter

Inperium lobbying by quarter
Inperium lobbying by quarter
QuarterAmountReports
Q3 2024$30K1
Q4 2024$30K1
Q1 2025$30K1
Q2 2025$30K1
Q3 2025$30K1
Q4 2025$30K1
Q1 2026$30K1
Q2 2026$30K1
Q3 2026$00

By issue

  • Health issues$240K · 8 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Health Resources & Services Administration (HRSA)8 reports
  • HOUSE OF REPRESENTATIVES8 reports
  • SENATE8 reports

Firms it paid

Firm
Buchanan Ingersoll & Rooney PC$240K8 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
07/20for Q2Buchanan Ingersoll & Rooney PC$30K
04/20for Q1Buchanan Ingersoll & Rooney PC$30K
01/20for Q4 2025Buchanan Ingersoll & Rooney PC$30K
25/10/20for Q3 2025Buchanan Ingersoll & Rooney PC$30K
25/07/22for Q2 2025Buchanan Ingersoll & Rooney PC$30K
25/04/21for Q1 2025Buchanan Ingersoll & Rooney PC$30K
25/01/21for Q4 2024Buchanan Ingersoll & Rooney PC$30K
24/10/24for Q3 2024Buchanan Ingersoll & Rooney PC$30K
24/10/23for Q3 2024Buchanan Ingersoll & Rooney PCUnder $5,000